Liver cancer research receives boost from Sir Owen Glenn

Liver cancer research receives boost from cancer patient and philanthropist Sir Owen Glenn

The $3 million donation from philanthropist and businessman, Sir Owen Glenn will fund a major liver cancer research program for the next three years.

“I am privileged to support the important work of the St George and Sutherland Medical Research Foundation. By investing in liver cancer research, I hope we can find better, more effective ways of treating this disease – and preventing it all together,” said Sir Owen, Glenn who is currently undergoing treatment for liver cancer himself.

The Sir Owen Glenn Liver Cancer Research Program ultimately aims to prevent liver cancer but will also work to optimise the treatment of the cancer once it develops.

The research will be led by Australia’s first Microbiome Research Centre (MRC), combining collaborative efforts from main teaching hospitals, leading Australian universities, research institutes and international collaborators who are leaders in the field of cancer.

The microbiome is the most exciting and promising new frontier in medicine and will deliver significant benefits.

For patients with liver cancer, the research is likely to impact on success of its treatment. For example, manipulation of the microbiome may positively impact the body’s immunotherapy response to liver cancer.

At the pre-cancer stage, the results will have key preventative implications in terms of earlier identification of patients at risk of developing liver cancer.

Lead scientist, Professor Amany Zekry says results are expected within three years, and the findings will pave the way for human interventional trials.

Ms Jacquie Stratford, CEO of the St George and Sutherland Medical Research Foundation said Sir Owen’s gift was the largest single private donation the St George and Sutherland Medical Research Foundation have received.

“Sir Owen’s generous donation has established a world class research programme in liver cancer, one that will deliver real progress in the fight against this global killer.”

The Sir Owen Glenn Liver Cancer Project was announced today at the St George and Sutherland Clinical School.  Joining Sir Owen Glenn at the launch was Professor Emad El-Omar, UNSW’s Professor of Medicine at the St George and Sutherland Clinical School and the director of the MRC, Dr Francis Chu, Professor Amany Zekry, Professor Michael Grimm, Professor of Medicine, Dean UNSW and Jacquie Stratford, CEO St George and Sutherland Medical Research Foundation.

The Microbiome Research Centre is a partnership between St George & Sutherland Medical Research Foundation, The University of NSW and the South Eastern Sydney Local Health District.